Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm Syncona
websitegoogle

Syncona

map marker logo London |  U.K.

Investor TypeFirm
Type of FundVC
IndustriesIT (& TMT) • BioTech • IoT (& Wearables) • Life Science • Oncology
StagesSeed
InvestingUnited Kingdom
Investment Range $117,550,000  -  $117,550,000

Investors who are part of this firm

About The Fund

Syncona is a UK-based venture capital investment subsidiary of Wellcome Trust that engages in the founding, building, and funding of global leaders in life science. With its foundation in London in 2012, Syncona operates with a unique model that combines the capital growth dynamics of a life science company with the liquidity and diversification of a fund. The firm is characterized by a hands-on approach to invest in transformative healthcare technologies and businesses, particularly in the fields of IT & TMT, BioTech, IoT & Wearables, Life Science, and Oncology. Syncona invests with a long-term perspective, aiming to build strong, standalone businesses that can produce innovative treatments for patients. Each investment aligns with a clear patient impact framework, ensuring both societal and shareholder value. Syncona's venture capital activities involve seed investments with both minimum and maximum amounts set at £117,550,000. The investment process focuses on creating a diversified portfolio of 20-25 leading healthcare companies through close partnerships with scientists and entrepreneurs, fostering environments that support growth and success. This structured and disciplined approach includes stages from pre-clinical, clinical, to late-stage companies, emphasizing value maximization throughout the investment cycle. Furthermore, Syncona is committed to sustainability and responsible investment, including efforts to inspire and empower their people, conduct ethical business practices, achieve net zero targets, and make significant charitable donations, particularly in healthcare. Syncona's portfolio contains a range of businesses at varying stages of development, such as Autolus Therapeutics, Quell Therapeutics, and Purespring Therapeutics, reflecting the fund’s belief in unlocking potential from innovative science to transform patient lives. The fund has also shown dedication to contributing positively to society beyond financial means, as demonstrated by the activities of The Syncona Foundation.

Syncona 's investments on record

Freeline Therapeutics $117,550,000.00 Later stage VC
Resolution Therapeutics $35,180,000.00 Later stage VC

Similar Investment Firms

Similar Investor Plutus PowerGen
Plutus PowerGen
Similar Investor The Royal Society of London
The Royal Society of London
Similar Investor RD Capital Partners
RD Capital Partners
Similar Investor Medicxi
Medicxi
Similar Investor Medicxi Ventures
Medicxi Ventures
Similar Investor Manhattan Atlantic Capital
Manhattan Atlantic Capital
Similar Investor Cambridge Enterprise
Cambridge Enterprise
Similar Investor Cambridge Angels
Cambridge Angels
Similar Investor ET Capital
ET Capital
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo